“MYLERAN”: A REVIEW OF ITS ACTION AND A REPORT ON ITS USE IN CHRONIC MYELOID LEUCHÆMIA
- 1 April 1955
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 1 (18) , 636-641
- https://doi.org/10.5694/j.1326-5377.1955.tb38079.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemiaCancer, 1954
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA RESULTS OF TREATMENTThe Lancet, 1953
- MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTIONThe Lancet, 1953
- TITRATED, REGULARLY SPACED RADIOACTIVE PHOSPHORUS OR SPRAY ROENTGEN THERAPY OF LEUKEMIASArchives of internal medicine (1960), 1951
- Chromosome Alteration and Tumour Inhibition by Nitrogen Mustards: the Hypothesis of Cross-linking AlkylationNature, 1950
- Chromosome Alteration and Tumour Inhibition by Nitrogen Mustards: the Hypothesis of Cross-linking AlkylationNature, 1950
- New Cytotoxic Agents with Tumour-Inhibitory ActivityNature, 1950
- Mode of Production of Chromosome Abnormalities by the Nitrogen Mustards The Possible Role of Cross-LinkingNature, 1949
- Effects upon tumours of Various HaloalkylarylaminesNature, 1948